Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00805896
What this trial is testing

Songyou Granule and Transarterial Chemoembolization for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaUnresectable
Fudan University 260
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682454
What this trial is testing

Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver Cancer, Adult
University of California, San Francisco 50
Large-scale testing (Phase 3)Ended earlyNCT02867280
What this trial is testing

Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection

Who this might be right for
Hepatocellular CarcinomaRecurrence
Sun Yat-sen University 154
Early research (Phase 1)Study completedNCT01129570
What this trial is testing

Siliphos in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Abby Siegel 3
Large-scale testing (Phase 3)Study completedNCT03062358
What this trial is testing

Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 453
Large-scale testing (Phase 3)Active Not RecruitingNCT03017326
What this trial is testing

Paediatric Hepatic International Tumour Trial

Who this might be right for
HepatoblastomaCarcinoma, Hepatocellular
University of Birmingham 450
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Testing effectiveness (Phase 2)UnknownNCT06085976
What this trial is testing

Efficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.

Who this might be right for
Hepatic CarcinomaHepatic Metastasis
Clinica Universidad de Navarra, Universidad de Navarra 62
Early research (Phase 1)Active Not RecruitingNCT07118176
What this trial is testing

Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers

Who this might be right for
Anal CarcinomaBladder CarcinomaBreast Carcinoma+31 more
Jonsson Comprehensive Cancer Center 30
Very early researchLooking for participantsNCT06418659
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC Patients

Who this might be right for
Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363356
What this trial is testing

Drug Sensitivity Testing-Based Tumor Organoids to Guide Adjuvant Therapy After Hepatectomy for Primary Liver Cancer

Who this might be right for
Hepatocellular Carcinoma Resectable
Eastern Hepatobiliary Surgery Hospital 56
Testing effectiveness (Phase 2)Study completedNCT02560779
What this trial is testing

Trial of TRC105 and Sorafenib in Patients With HCC

Who this might be right for
Hepatocellular Carcinoma
Tracon Pharmaceuticals Inc. 27
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00775073
What this trial is testing

Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001

Who this might be right for
Hepatocellular Carcinoma
Gerhard Treiber 33
Not applicableEnded earlyNCT04315883
What this trial is testing

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Who this might be right for
HepatoblastomaHepatocellular CarcinomaRhabdoid Tumor of Liver+3 more
Nemours Children's Clinic 3
Testing effectiveness (Phase 2)Study completedNCT01246986
What this trial is testing

LY2157299 in Participants With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Eli Lilly and Company 204
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Testing effectiveness (Phase 2)UnknownNCT04888546
What this trial is testing

TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis

Who this might be right for
Patients With Resectable Hepatocellular Carcinoma Who Are at High Risk of Recurrence or Metastasi
Chinese Academy of Medical Sciences 20
Early research (Phase 1)WithdrawnNCT04270461
What this trial is testing

NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

Who this might be right for
Hepatocellular CarcinomaGlioblastomaMedulloblastoma+1 more
Jiujiang University Affiliated Hospital
Next Page